HK

Hiroaki Kitano

Active Director Director DIN 09684802
DIN 09684802 First appointment Jul 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2022
Shareholding value •••• Premium profile

About Hiroaki Kitano

Data last updated:

Hiroaki Kitano is a Director at Iom Bioworks Private Limited (since 2022). The company operates in Healthcare. Iom Bioworks Private Limited reported revenue of ₹28.1 Lakh (FY 2025).

DIN 09684802
Primary Designation Director
Industry Healthcare
First Appointment 25 Jul 2022
Oldest Company Age 4 yrs
Largest company Iom Bioworks Private Limited · ₹28.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Iom Bioworks Private Limited U73200KA2022PTC164214
Director25 Jul 20222022₹28.1 Lakh (FY 2025)Active

Board colleagues of Hiroaki Kitano

Directorship timeline

Open interactive timeline →
Iom Bioworks Private Limited
Premium access

Shareholding and investment profile for Hiroaki Kitano

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hiroaki Kitano

Hiroaki Kitano currently holds 1 directorship: Iom Bioworks Private Limited (Director, since 25 Jul 2022, revenue ₹28.1 Lakh (FY 2025)).

Hiroaki Kitano was first appointed on 25 Jul 2022 as Director at Iom Bioworks Private Limited.

The current boards of Hiroaki Kitano's companies include Bipin Pradeep Kumar (Iom Bioworks Private Limited), Samik Ghosh (Iom Bioworks Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available